Molecular mechanisms of resistance of leukemia to imatinib mesylate - ScienceDirect
IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
![PDF] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/800ff3e36d003a19dad5dd24b03c15a74f708084/14-Figure3-1.png "PDF] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). | Semantic Scholar")
PDF] Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). | Semantic Scholar
Response and Resistance to BCR-ABL1-Targeted Therapies
Managing resistance in chronic myeloid leukemia. | Semantic Scholar
Imatinib: Basic Results | Oncohema Key
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal
Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours | Oncogene
Imatinib Pathway, Pharmacokinetics/Pharmacodynamics
A therapeutically targetable mechanism of BCR-ABL–independent imatinib resistance in chronic myeloid leukemia | Science Translational Medicine
Imatinib Resistance Mutation Analysis - Kinase Domain Test in Delhi | GDIC
Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way - ScienceDirect
Mechanisms of resistance towards imatinib. (a) Imatinib is available... | Download Scientific Diagram
Frontiers | Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells | PLOS ONE
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL: Cell
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. | Semantic Scholar
Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics | PLOS Computational Biology
Mechanisms of CML cells resistance to TKI. BCR-ABL dependent mechanisms... | Download Scientific Diagram
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators - ScienceDirect
Mechanisms of imatinib resistance in CML. Clinical imatinib resistance... | Download Scientific Diagram
Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia | SpringerLink
Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics
